Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

Related Articles by Review for PubMed (Select 19812437)

1.

Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.

Tashiro M, McKimm-Breschkin JL, Saito T, Klimov A, Macken C, Zambon M, Hayden FG; Neuraminidase Inhibitor Susceptibility Network.

Antivir Ther. 2009;14(6):751-61. doi: 10.3851/IMP1194.

PMID:
19812437
2.

Influenza virus susceptibility and resistance to oseltamivir.

Aoki FY, Boivin G, Roberts N.

Antivir Ther. 2007;12(4 Pt B):603-16. Review.

PMID:
17944268
3.

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.

McKimm-Breschkin JL.

Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1:25-36. doi: 10.1111/irv.12047. Review.

PMID:
23279894
4.

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.

Ikematsu H, Kawai N.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Review.

PMID:
21973296
5.

Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.

Nguyen HT, Fry AM, Gubareva LV.

Antivir Ther. 2012;17(1 Pt B):159-73. doi: 10.3851/IMP2067. Epub 2012 Feb 3. Review.

PMID:
22311680
6.

The potential impact of neuraminidase inhibitor resistant influenza.

Lackenby A, Thompson CI, Democratis J.

Curr Opin Infect Dis. 2008 Dec;21(6):626-38. doi: 10.1097/QCO.0b013e3283199797. Review.

PMID:
18978531
7.

Influenza virus resistance to antiviral therapy.

van der Vries E, Schutten M, Fraaij P, Boucher C, Osterhaus A.

Adv Pharmacol. 2013;67:217-46. doi: 10.1016/B978-0-12-405880-4.00006-8. Review.

PMID:
23886002
8.

Widespread use of neuraminidase inhibitors in Japan.

Sugaya N.

J Infect Chemother. 2011 Oct;17(5):595-601. doi: 10.1007/s10156-011-0288-0. Epub 2011 Aug 18. Review.

PMID:
21850418
9.

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG.

J Infect Dis. 2006 Mar 15;193(6):760-4. Epub 2006 Feb 13. Review.

10.

Treatment of influenza with neuraminidase inhibitors: virological implications.

Roberts NA.

Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1895-7. Review.

11.

Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.

Govorkova EA.

Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1:50-7. doi: 10.1111/irv.12044. Review.

PMID:
23279897
12.

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.

Ferraris O, Lina B.

J Clin Virol. 2008 Jan;41(1):13-9. Epub 2007 Dec 11. Review.

PMID:
18055254
13.

Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.

Hayden F, Klimov A, Tashiro M, Hay A, Monto A, McKimm-Breschkin J, Macken C, Hampson A, Webster RG, Amyard M, Zambon M.

Antivir Ther. 2005;10(8):873-7. Review. Erratum in: Antivir Ther. 2006;11(1):130.

PMID:
16430192
14.

Systematic review of influenza resistance to the neuraminidase inhibitors.

Thorlund K, Awad T, Boivin G, Thabane L.

BMC Infect Dis. 2011 May 19;11:134. doi: 10.1186/1471-2334-11-134. Review.

15.

Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors.

Okomo-Adhiambo M, Sheu TG, Gubareva LV.

Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1:44-9. doi: 10.1111/irv.12051. Review.

PMID:
23279896
16.
17.

Influenza in the tropics.

Moura FE.

Curr Opin Infect Dis. 2010 Oct;23(5):415-20. doi: 10.1097/QCO.0b013e32833cc955. Review.

PMID:
20644472
18.

Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.

Dutkowski R.

J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii11-ii24. doi: 10.1093/jac/dkq012. Review.

19.

[The molecular basis of resistance to anti-influenza drugs].

Hatakeyama S, Kawaoka Y.

Nihon Rinsho. 2006 Oct;64(10):1845-52. Review. Japanese.

PMID:
17037359
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk